• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白酶体激活剂PA28在MHC I类抗原加工中的作用。

The role of the proteasome activator PA28 in MHC class I antigen processing.

作者信息

Sijts Alice, Sun Yuancheng, Janek Katarina, Kral Sylvie, Paschen Annettte, Schadendorf Dirk, Kloetzel Peter-M

机构信息

Institut für Biochemie, Charité-Medizinische Fakültät der, Humboldt Universität zu Berlin, Monbijoustrasse 2, 10117 Berlin, Germany.

出版信息

Mol Immunol. 2002 Oct;39(3-4):165-9. doi: 10.1016/s0161-5890(02)00099-8.

DOI:10.1016/s0161-5890(02)00099-8
PMID:12200048
Abstract

The proteasome system is the major source for the generation of viral antigens and tumor antigens presented by major histocompatibility complex class I (MHC class I) molecules. A specific feature of the proteasomal antigen processing machinery is that five of its components are inducible by IFN-gamma. Two of these are the alpha and beta subunits of the proteasome activator PA28. Our results show that PA28 selectively up-regulates the presentation of viral MHC class I epitopes and that down regulation PA28 in tumor cells results in impaired presentation of a human TRP2 tumor antigen.

摘要

蛋白酶体系统是主要组织相容性复合体I类(MHC I类)分子呈递的病毒抗原和肿瘤抗原产生的主要来源。蛋白酶体抗原加工机制的一个特定特征是其五个组分可被γ干扰素诱导。其中两个是蛋白酶体激活剂PA28的α和β亚基。我们的结果表明,PA28选择性地上调病毒MHC I类表位的呈递,并且在肿瘤细胞中下调PA28会导致人TRP2肿瘤抗原的呈递受损。

相似文献

1
The role of the proteasome activator PA28 in MHC class I antigen processing.蛋白酶体激活剂PA28在MHC I类抗原加工中的作用。
Mol Immunol. 2002 Oct;39(3-4):165-9. doi: 10.1016/s0161-5890(02)00099-8.
2
Expression of the proteasome activator PA28 rescues the presentation of a cytotoxic T lymphocyte epitope on melanoma cells.蛋白酶体激活剂PA28的表达可挽救黑色素瘤细胞上细胞毒性T淋巴细胞表位的呈递。
Cancer Res. 2002 May 15;62(10):2875-82.
3
Differential influence on cytotoxic T lymphocyte epitope presentation by controlled expression of either proteasome immunosubunits or PA28.蛋白酶体免疫亚基或PA28的可控表达对细胞毒性T淋巴细胞表位呈递的差异影响
J Exp Med. 2000 Aug 21;192(4):483-94. doi: 10.1084/jem.192.4.483.
4
The role of the ubiquitin-proteasome pathway in MHC class I antigen processing: implications for vaccine design.泛素-蛋白酶体途径在MHC I类抗原加工中的作用:对疫苗设计的启示。
Curr Mol Med. 2001 Dec;1(6):665-76. doi: 10.2174/1566524013363230.
5
Tumor necrosis factor-alpha induces coordinated changes in major histocompatibility class I presentation pathway, resulting in increased stability of class I complexes at the cell surface.肿瘤坏死因子-α 诱导主要组织相容性复合体 I 类呈递途径发生协同变化,导致 I 类复合物在细胞表面的稳定性增加。
Blood. 2001 Aug 15;98(4):1108-15. doi: 10.1182/blood.v98.4.1108.
6
Molecular cloning of proteasome activator PA28-beta subunit of large yellow croaker (Pseudosciana crocea) and its coordinated up-regulation with MHC class I alpha-chain and beta 2-microglobulin in poly I:C-treated fish.大黄鱼(Pseudosciana crocea)蛋白酶体激活剂PA28-β亚基的分子克隆及其在聚肌胞苷酸处理的鱼中与MHC I类α链和β2-微球蛋白的协同上调
Mol Immunol. 2007 Feb;44(6):1190-7. doi: 10.1016/j.molimm.2006.06.024. Epub 2006 Aug 9.
7
Bipartite regulation of different components of the MHC class I antigen-processing machinery during dendritic cell maturation.树突状细胞成熟过程中MHC I类抗原加工机制不同组分的双向调节。
Int Immunol. 2001 Dec;13(12):1515-23. doi: 10.1093/intimm/13.12.1515.
8
Interferon-gamma, the functional plasticity of the ubiquitin-proteasome system, and MHC class I antigen processing.干扰素-γ、泛素-蛋白酶体系统的功能可塑性与MHC I类抗原加工
Immunol Rev. 2005 Oct;207:19-30. doi: 10.1111/j.0105-2896.2005.00308.x.
9
The proteasome and MHC class I antigen processing.蛋白酶体与MHC I类抗原加工
Biochim Biophys Acta. 2004 Nov 29;1695(1-3):225-33. doi: 10.1016/j.bbamcr.2004.10.004.
10
Allele-selective effect of PA28 in MHC class I antigen processing.PA28在MHC I类抗原加工过程中的等位基因选择性效应。
J Immunol. 2008 Aug 1;181(3):1655-64. doi: 10.4049/jimmunol.181.3.1655.

引用本文的文献

1
Not Just PA28γ: What We Know About the Role of PA28αβ in Carcinogenesis.不仅仅是PA28γ:我们对PA28αβ在致癌作用中的作用的了解。
Biomolecules. 2025 Jun 16;15(6):880. doi: 10.3390/biom15060880.
2
The Significant Role of PA28αβ in CD8 T Cell-Mediated Graft Rejection Contrasts with Its Negligible Impact on the Generation of MHC-I Ligands.PA28αβ 在 CD8 T 细胞介导的移植物排斥反应中具有重要作用,而其对 MHC-I 配体的产生影响可以忽略不计。
Int J Mol Sci. 2024 May 22;25(11):5649. doi: 10.3390/ijms25115649.
3
YWHAH, a member of 14-3-3 family proteins, and PSME2, the proteasome activator subunit 2, are key host factors of Japanese encephalitis virus infection.
YWHAH,一种 14-3-3 家族蛋白成员,以及 PSME2,蛋白酶体激活亚基 2,是日本脑炎病毒感染的关键宿主因子。
BMC Med Genomics. 2023 Jul 10;16(1):161. doi: 10.1186/s12920-023-01589-6.
4
Combination Analysis of Ferroptosis and Immune Status Predicts Patients Survival in Breast Invasive Ductal Carcinoma.铁死亡与免疫状态联合分析预测乳腺浸润性导管癌患者的生存。
Biomolecules. 2023 Jan 11;13(1):147. doi: 10.3390/biom13010147.
5
Intersections of Ubiquitin-Proteosome System and Autophagy in Promoting Growth of Glioblastoma Multiforme: Challenges and Opportunities.泛素蛋白酶体系统与自噬在促进多形性胶质母细胞瘤生长中的相互作用:挑战与机遇。
Cells. 2022 Dec 15;11(24):4063. doi: 10.3390/cells11244063.
6
Wnt5A signaling supports antigen processing and CD8 T cell activation.Wnt5A 信号支持抗原加工和 CD8 T 细胞激活。
Front Immunol. 2022 Aug 26;13:960060. doi: 10.3389/fimmu.2022.960060. eCollection 2022.
7
Upregulated Proteasome Subunits in COVID-19 Patients: A Link with Hypoxemia, Lymphopenia and Inflammation.COVID-19 患者中上调的蛋白酶体亚基:与低氧血症、淋巴细胞减少和炎症有关。
Biomolecules. 2022 Mar 13;12(3):442. doi: 10.3390/biom12030442.
8
PA28γ-20S proteasome is a proteolytic complex committed to degrade unfolded proteins.PA28γ-20S 蛋白酶体是一种负责降解未折叠蛋白质的蛋白水解复合物。
Cell Mol Life Sci. 2021 Dec 16;79(1):45. doi: 10.1007/s00018-021-04045-9.
9
Immunoproteasome Function in Normal and Malignant Hematopoiesis.免疫蛋白酶体在正常和恶性造血中的功能。
Cells. 2021 Jun 22;10(7):1577. doi: 10.3390/cells10071577.
10
Immune profiles of male giant panda (Ailuropoda melanoleuca) during the breeding season.大熊猫(Ailuropoda melanoleuca)在繁殖季节的免疫特征。
BMC Genomics. 2021 Feb 28;22(1):143. doi: 10.1186/s12864-021-07456-x.